Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

MicroRNA-181b regulates NF-κB-mediated vascular inflammation.

Sun X, Icli B, Wara AK, Belkin N, He S, Kobzik L, Hunninghake GM, Vera MP; MICU Registry, Blackwell TS, Baron RM, Feinberg MW.

J Clin Invest. 2012 Jun;122(6):1973-90. doi: 10.1172/JCI61495. Epub 2012 May 24.

2.

Systemic delivery of microRNA-181b inhibits nuclear factor-κB activation, vascular inflammation, and atherosclerosis in apolipoprotein E-deficient mice.

Sun X, He S, Wara AK, Icli B, Shvartz E, Tesmenitsky Y, Belkin N, Li D, Blackwell TS, Sukhova GK, Croce K, Feinberg MW.

Circ Res. 2014 Jan 3;114(1):32-40. doi: 10.1161/CIRCRESAHA.113.302089. Epub 2013 Oct 1.

3.

MicroRNA-181b inhibits thrombin-mediated endothelial activation and arterial thrombosis by targeting caspase recruitment domain family member 10.

Lin J, He S, Sun X, Franck G, Deng Y, Yang D, Haemmig S, Wara AK, Icli B, Li D, Feinberg MW.

FASEB J. 2016 Sep;30(9):3216-26. doi: 10.1096/fj.201500163R. Epub 2016 Jun 13.

PMID:
27297585
4.

Mediators released from LPS-challenged lungs induce inflammatory responses in liver vascular endothelial cells and neutrophilic leukocytes.

Markovic N, McCaig LA, Stephen J, Mizuguchi S, Veldhuizen RA, Lewis JF, Cepinskas G.

Am J Physiol Gastrointest Liver Physiol. 2009 Dec;297(6):G1066-76. doi: 10.1152/ajpgi.00278.2009. Epub 2009 Oct 8.

5.

4F, apolipoprotein AI mimetic peptide, attenuates acute lung injury and improves survival in endotoxemic rats.

Kwon WY, Suh GJ, Kim KS, Kwak YH, Kim K.

J Trauma Acute Care Surg. 2012 Jun;72(6):1576-83. doi: 10.1097/TA.0b013e3182493ab4.

PMID:
22695425
6.

In vivo and in vitro inhibitory effects of a traditional Chinese formulation on LPS-stimulated leukocyte-endothelial cell adhesion and VCAM-1 gene expression.

Wu YH, Chuang SY, Hong WC, Lai YJ, Chang YL, Pang JH.

J Ethnopharmacol. 2012 Mar 6;140(1):55-63. doi: 10.1016/j.jep.2011.12.002. Epub 2011 Dec 9.

PMID:
22226975
7.

MicroRNA-126 contributes to renal microvascular heterogeneity of VCAM-1 protein expression in acute inflammation.

Asgeirsdóttir SA, van Solingen C, Kurniati NF, Zwiers PJ, Heeringa P, van Meurs M, Satchell SC, Saleem MA, Mathieson PW, Banas B, Kamps JA, Rabelink TJ, van Zonneveld AJ, Molema G.

Am J Physiol Renal Physiol. 2012 Jun 15;302(12):F1630-9. doi: 10.1152/ajprenal.00400.2011. Epub 2012 Mar 14.

8.

MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro.

Fang Y, Shi C, Manduchi E, Civelek M, Davies PF.

Proc Natl Acad Sci U S A. 2010 Jul 27;107(30):13450-5. doi: 10.1073/pnas.1002120107. Epub 2010 Jul 12.

9.

Andrographolide protects against LPS-induced acute lung injury by inactivation of NF-κB.

Zhu T, Wang DX, Zhang W, Liao XQ, Guan X, Bo H, Sun JY, Huang NW, He J, Zhang YK, Tong J, Li CY.

PLoS One. 2013;8(2):e56407. doi: 10.1371/journal.pone.0056407. Epub 2013 Feb 21.

10.
11.

Distinct mechanisms for N-acetylcysteine inhibition of cytokine-induced E-selectin and VCAM-1 expression.

Faruqi RM, Poptic EJ, Faruqi TR, De La Motte C, DiCorleto PE.

Am J Physiol. 1997 Aug;273(2 Pt 2):H817-26.

PMID:
9277499
12.

MiR-221 activates the NF-κB pathway by targeting A20.

Zhao D, Zhuang N, Ding Y, Kang Y, Shi L.

Biochem Biophys Res Commun. 2016 Mar 25;472(1):11-8. doi: 10.1016/j.bbrc.2015.11.009. Epub 2015 Nov 6.

PMID:
26549234
13.

Docosahexaenoic acid attenuates VCAM-1 expression and NF-κB activation in TNF-α-treated human aortic endothelial cells.

Wang TM, Chen CJ, Lee TS, Chao HY, Wu WH, Hsieh SC, Sheu HH, Chiang AN.

J Nutr Biochem. 2011 Feb;22(2):187-94. doi: 10.1016/j.jnutbio.2010.01.007. Epub 2010 Jun 22.

PMID:
20573493
15.

Endothelial MKK3 is a critical mediator of lethal murine endotoxemia and acute lung injury.

Mannam P, Zhang X, Shan P, Zhang Y, Shinn AS, Zhang Y, Lee PJ.

J Immunol. 2013 Feb 1;190(3):1264-75. doi: 10.4049/jimmunol.1202012. Epub 2012 Dec 28.

16.

A preferential p110alpha/gamma PI3K inhibitor attenuates experimental inflammation by suppressing the production of proinflammatory mediators in a NF-kappaB-dependent manner.

Dagia NM, Agarwal G, Kamath DV, Chetrapal-Kunwar A, Gupte RD, Jadhav MG, Dadarkar SS, Trivedi J, Kulkarni-Almeida AA, Kharas F, Fonseca LC, Kumar S, Bhonde MR.

Am J Physiol Cell Physiol. 2010 Apr;298(4):C929-41. doi: 10.1152/ajpcell.00461.2009. Epub 2010 Jan 20.

17.
18.

MicroRNAs in NF-kappaB signaling.

Ma X, Becker Buscaglia LE, Barker JR, Li Y.

J Mol Cell Biol. 2011 Jun;3(3):159-66. doi: 10.1093/jmcb/mjr007. Epub 2011 Apr 18. Review.

19.

Liver kinase B1 is required for thromboxane receptor-dependent nuclear factor-κB activation and inflammatory responses.

He J, Zhou Y, Xing J, Wang Q, Zhu H, Zhu Y, Zou MH.

Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1297-305. doi: 10.1161/ATVBAHA.113.301296. Epub 2013 Mar 28.

20.

MicroRNA-146 inhibits thrombin-induced NF-κB activation and subsequent inflammatory responses in human retinal endothelial cells.

Cowan C, Muraleedharan CK, O'Donnell JJ 3rd, Singh PK, Lum H, Kumar A, Xu S.

Invest Ophthalmol Vis Sci. 2014 Jul 1;55(8):4944-51. doi: 10.1167/iovs.13-13631.

PMID:
24985472
Items per page

Supplemental Content

Write to the Help Desk